Quinn Opportunity Partners LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 81,588 shares of the pharmacy operator’s stock, valued at approximately $761,000.
Several other hedge funds also recently modified their holdings of the company. First Financial Corp IN raised its position in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $26,000. Riverview Trust Co boosted its position in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after buying an additional 1,590 shares during the period. Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC increased its position in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.
Analyst Ratings Changes
Several analysts recently weighed in on WBA shares. Royal Bank of Canada boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. StockNews.com assumed coverage on Walgreens Boots Alliance in a research note on Friday. They issued a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Evercore ISI boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $10.59.
Walgreens Boots Alliance Stock Performance
Shares of WBA opened at $10.78 on Friday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $18.83. The company has a market cap of $9.32 billion, a PE ratio of -1.05, a P/E/G ratio of 1.31 and a beta of 0.67. The stock has a 50-day moving average of $10.75 and a 200-day moving average of $10.07. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion during the quarter, compared to analysts’ expectations of $37.90 billion. During the same quarter last year, the firm posted $1.20 earnings per share. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
- Five stocks we like better than Walgreens Boots Alliance
- 3 Fintech Stocks With Good 2021 Prospects
- JPMorgan is a Buy, if You Can Handle The Volatility
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- United States Steel’s Crash: An Unmissable Buying Opportunity
- Why Are Stock Sectors Important to Successful Investing?
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.